A new effort to keep the investors
News Article
Global Wholehealth Partners Corporation Declares Special Common Stock Dividend
6:00am ET 1/13/2022 Globe Newswire
via NewMediaWire -- On January 13, 2022, Global Wholehealth Partners Corporation (the "Company") (OTC: GWHP) announced today that its Board of Directors declared a special one-time dividend of two shares of common stock for each one share of common stock of the Company, payable on April 1, 2022, to the shareholders of record at the close of business on March 31, 2022.
About Global Wholehealth Partners Corporation
The Company's executive offices are located in San Clemente, California with manufacturing, warehousing and laboratories in San Diego and Oceanside California. The Company was founded to develop, manufacture and market in vitro diagnostic (IVD) tests for over-the-counter (OTC or consumer), and point-of-care (POC or professional) use markets. The Company currently manufactures and markets a range of diagnostic test kits for consumer use through over-the-counter (OTC) sales, and for use by health care professionals, generally located at medical clinics, physician offices and hospitals known as Points-of-Care (POC), in the United States. These test kits are known as in vitro diagnostic test kits or "IVD" products. GWHP has evolved into a leading Health Care company by expanding itself from diagnostic products to the full service health care company. GWHP has partnered with several companies in the health care industry which broaden the scope of GWHP business, giving GWHP a strong controlling vertical and horizontal integration in the health care industry.
Media Contact:
Name: Charles Strongo,
